Corisma

About:

Corisma develops a catheter implanted circulatory assist device designed to treat patients suffering from advanced heart failure.

Website: https://www.corismacv.com/

Top Investors: Propel(X), China Grand Pharmaceutical and Healthcare Holdings

Description:

Spun out of the Bonde Artificial Heart Lab at Yale University, Bonde Innovations is developing an innovative, catheter implanted circulatory assist device, CoRISMA, to treat Class 3 and Class 4 heart failure patients. With $2M+ grant funding, CoRISMA has been designed to improve patients' quality of life and reduce cost and invasiveness associated with the current therapies. All the components of the devices have been prototyped and tested at Yale.

Total Funding Amount:

$27M

Headquarters Location:

Bethany, Connecticut, United States

Founded Date:

2018-08-09

Contact Email:

info(AT)corismacv.com

Founders:

Mike Theran

Number of Employees:

1-10

Last Funding Date:

2021-08-30

IPO Status:

Private

Industries:

© 2025 bioDAO.ai